
The Allevi Liver dECM promises the fabrication of liver tissue that has a more representative physiological function. The product uses a combination of a type I collagen Allevi bioink for patterning as well as Xylyx Bio’s highly desired liver-specific TissueSpec® ECM to enhance specialized biological response.
Xylyx Bio products for cell culture are obtained from porcine or human tissue sources and processed to various formats, enabling cell culture models that are significantly more predictive of physiology. Their 3D TissueSpec® ECM hydrogels and scaffolds provide support to cell culture models, facilitating the acceleration of drug discovery, development and tissue regeneration.
“We are thrilled to partner with Allevi and share our expertise in tissue-specific ECM,” stated Andrea Nye, Chief Executive Officer at Xylyx Bio. “Recognizing the importance of the native cellular microenvironment, Xylyx Bio harnesses the body’s innate biology in the form of tissue-specific extracellular matrix. By sourcing extracellular matrix from native organs and tissues, Xylyx produces tissue-specific substrates that comprise both the mechanical properties and complex ratios of ECM components specific and unique to each tissue and organ type.”
Founded in 2014, Allevi claims that its “mission is to provide users the ability to design, engineer, and manufacture 3D tissue.” To deliver important building blocks and provide users with the best experience possible to drive new scientific discoveries, Allevi is hopeful that the new dECM bioink will provide scientists a revolutionary approach that allows scientists to print 3D tissue structures with biochemical and mechanical features inherent in human physiology.
[Images: Allevi and Xylyx Bio]
Xylyx Bio’s Co-founder and Chief Strategy Officer, John O’Neil, added that a “deeper understanding of the comprehensive nature of tissues and cells and their interaction with the cellular microenvironment – that is, the extracellular matrix – holds great promise to lead to a paradigm shift in 3D bioprinting, allowing researchers to study physiologic activity of cells in vitro towards a better understanding of disease and development of more effective drugs and treatments.”
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
Upload your 3D Models and get them printed quickly and efficiently.
You May Also Like
U.S. Congress Calls Out 3D Printing in Proposal for Commercial Reserve Manufacturing Network
Last week, the U.S. House of Representatives’ Appropriations Committee moved the FY 2026 defense bill forward to the House floor. Included in the legislation is a $131 million proposal for...
Rocket Lab and Nikon SLM Solutions Sign MoU for New Large Metal 3D Printing Systems
Nikon SLM Solutions has signed a Memorandum of Understanding (MoU) with Rocket Lab. The aerospace manufacturing firm wishes to reserve two new “ultra-large format metal additive manufacturing platforms.” This is...
BlueForge Alliance’s Tim Shinbara – a Driving Force for Defense Manufacturing
After an influential history within the manufacturing industry as VP and CTO of the Association for Manufacturing Technology (AMT), and a former (2020-2021) ASME Congressional Fellow in manufacturing, Tim Shinbara...
Robotics Company Comau Forms Partnership with 3D Printing OEM Roboze
Recently, the Italian robotics original equipment manufacturer (OEM) Comau announced the multifaceted approach it has taken to penetrating the additive manufacturing (AM) market. Comau, jointly owned by One Equity Partners and...